The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.
The Scientist
Most Recent
Despite drug company’s and patients’ pleading, an FDA panel votes to rescind Avastin approval for breast cancer.
A new study suggests that new cancer treatments generally go on sale in the United States before they reach European markets
Page 1 of 1
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Advertisement
Current Issue
